Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Led by a former OpenAI executive, Amazon’s AI lab focuses on the decisionmaking capabilities of next-generation software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback